Company Search:
Advanced Search
Sponsored Links
Novartis AG - ADR Company Snapshot
Novartis AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novartis AG with three other companies in this sector in UNITED STATES : Abbvie Inc (2020 sales of $45.80 billion of which 100% was pharmaceutical products), Bayer AG ($47.50 billion ), and Merck & Co. , Inc. ($47.99 billion ).

Sales Analysis. Novartis AG reported sales of $49.90 billion for the year ending December of 2020. This represents an increase of 2.6% versus 2019, when the company's sales were $48.62 billion. Despite this increase, sales are still below the level achieved in 2018, when Novartis AG reported sales of $53.17 billion. The sales level in 2020 was fairly close to the level five years ago: in 2015, Novartis AG had sales of $50.36 billion. Sales of Innovative Medicines saw an increase of 3.4% in 2020, from $37.71 billion to $39.01 billion. Not all segments of Novartis AG experienced an increase in sales in 2020: sales of Sandoz fell 0.9% to $9.65 billion.
  Stock Performance Chart for Novartis AG - ADR
  Stock Data: Recent Stock Performance:
  Current Price (2/19/2021): 88.41
(Figures in U.S. Dollars)
1 Week -3.9%   13 Weeks -8.8%  
4 Weeks 1.0%   52 Weeks -8.6%  
Novartis AG - ADR Key Data:
  Ticker: NVS Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 49,898,042,343
(Year Ending Jan 2021).
Employees: 105,794
  Currency: U.S. Dollars Market Cap: 199,525,637,264
  Fiscal Yr Ends: December Shares Outstanding: 2,256,822,048
  Share Type: Namenaktie Closely Held Shares: 144,045,064
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.